当前位置:首页 >> 农林牧渔 >>

中国综合性艾滋病研究项目


中国综合性艾滋病研究项目
China Integrated Programs for Research on AIDS (China CIPRA)
美国国立卫生研究院国际综合性艾滋病研究计划资助 Comprehensive International Program of Research on AIDS

1

Outline of China CIPRA
? CIPRA: Comprehensive International Program of Research on AIDS ? Sponsor: National Institute of Health, USA ? Corporation: National Center for STD/AIDS prevention and control, China CDC ? Period: July 1, 2002 to June 30, 2007 ? Budget: $15 millions ? Project provinces: Shanxi and Yunnan
2

Overall Goal
? To strengthen the existing HIV/AIDS research infrastructure in China and build the capacity to conduct multidisciplinary research to explore promising strategies for HIV/AIDS prevention, treatment and control.

3

Research Group
? The China CIPRA project is composed of 143 research staffs and 12 international consultants. ? The China CIPRA team is composed of 24 collaborating organizations including 13 domestic research institutes, 2 universities, and 2 hospitals, as well as 5 international universities and 2 research institutions.
4

Research Activity (I)
1. To estimate the prevalence and incidence of HIV-1 infection and to determine risk factors. 2. To evaluate the efficacy of more intensive, theoretically-based HIV skill-focused interventions for HIV+ adults. 3. To study viral and host factors that correlate with transmission of infection and factors that determine disease progression; and identify the immunodominant CTL epitopes and their MHC restricting elements in the most prevalent Chinese HIV subtypes as well as provide reagents for these studies. 5

Research Activity (II) 4. To characterize the clinical presentations of AIDS patients in China, to conduct clinical trials of antiviral drugs; 5. To develop vaccine candidates based on the Chinese prevalent strains and to conduct Phase I and Phase II clinical trials to evaluate its safety, immunogenicity and preliminary efficacy.

6

Research Team of China CIPRA
China CIPRA
P I : Yiming Shao Co-PI : Dexian Zheng , Zunyou Wu Advisor: Yi Zeng

Core A (Administration and training)
Leader: Yiming Shao Co-Leader: Dexian Zheng Zunyou Wu Xiaoyan Zhang

Core B
(Statistical and Data Management) Leader: ShuiGao Jin Co-Leader: Hui Li Yuhua Ruan Consultant: Steve Self

Core C (Central Laboratory)
Leader: Yan Jiang Co-Leader: DeXian Zheng Consultant: Haynes W. Sheppard Huyen Cao

Core D (Primate)
Leader: Fude Fang Co-Leader: QiHan Li XinMing Tu Consultant: Ruth Ruprecht, Harold M.McClure, Xiaofang Yu

Project 1 (Epidemiology)
Leader: Xiwen Zheng Co-Leader: Zunyou Wu Lü Fan Shenghan Lai

Project 2 (Behaviroal Intervention)
Leader: Zunyou Wu Co-Leader and Consultant: Roger Detels Rotheram-Borus Mary Jane

Project 3
(Viral Immune Corrlates of
Transmission and Progression)

Project 4 (Clinical Research)
Leader: Yunzhen Cao Co-Leader: Taisheng Li Linqi Zhang Xiaoping Chen Consultant: David Ho

Project 5
(Development of a novel vaccine against HIV/AIDS in China) Leader: Li Ruan Co-Leader: Yiming Shao Wei He Yichen Lu Xiaofang Yu

Consultant: Sten Vermund
Roger Detels , ShenhanLai

Leader: Yiming Shao Co-Leader: Yunqi Geng Judy Lieberman Kunxue Hong , Xing Hui Consultant: Haynes W.Sheppard Huyen Cao

7

CIPRA Coordinating Committee(CCC) ( )
? The CCC is responsible for supervising the general research direction according to the goals of Chinese AIDS control and prevention effort. It will provide guidance and support for the implementation of the China CIPRA research protocol and schedule. In addition, the committee will translate the experiences and results of the China CIPRA program to help advance AIDS research throughout the country.
8

Scientific Advisory Board (SAB)
? Made up of independent domestic and international experts who are not affiliated with the research team. ? Responsibilities include:
assisting with the planning and implementation of the research protocol; receiving research progress reports on a regular basis; aiding in the resolution of research difficulties encountered; providing an independent assessment on a regular basis of the current status of research project

9

Monitoring Group on Quality Control (MGQC)
? This committee is composed of Chinese and international experts and is in charge of maintaining the quality of data generated from this project. The main responsibility of this group is to supervise the quality of the study based on the overall aims and goals of the China CIPRA plan. They will oversee quality control in the following areas: epidemiology, laboratory techniques, experiment quality, clinical studies, and particular research related to the GCP standards. This group will also evaluate the appropriateness of the consent forms and any pertinent ethical issues. They will scrutinize and provide feedback to the researchers to assure the future quality of the research.

10

Network of China-CIPRA Operational Systems
National Institutes of Health (NIH)

CIPRA Coordinating Committee (CCC)

CIPRA Executive Committee (CEC)

Scientific Advisory Board (SAB)

Study Plan/Protocol Ethic Committee (EC)

Study Implementation (Project and Core Activities) Community Advisory Board(CAB) Monitoring Group on Quality Control (MGQC)

Supervision Action

Inform

Study Population

11

Summary of Progress
? ? ? ? ? Set up the administration structure and research team; Conducted preparation work at Shanxi local sites; Developed research protocols; Created SOPs for CIPRA team (on going); Organized training according to the plan;IRB, GCP, management, research techniques, etc. Some researchers were trained oversea ? Strengthened communication among projects and cores, and communication with international organizations. Created web site and newsletter (electronic/paper version).
12

Training Information Welcome
? ? ? ? Project Management and Coordination Leadership and Organization 2 to 3 month/course advanced course preferred

13

Contact information
Address: 4 Nan Wei Road, Room 510 Xuan Wu District Beijing, China 100050 Tel: 86-10-63045970; ; 63015577 ex. 6510 Fax: 86-10-63045970 E-mail: cipracn@public3.bta.net.cn Website: http://www.chinaids.org.cn/cipra

14

15


相关文章:
传染病专项2016年课题立项评审课题答辩顺序
逃逸研究 艾滋病免疫抑制疗法 和根治策略研究 课题责任单位 中国疾病预防控制中心...性相关肝癌术后转 移复发的预测诊断与精 准防治 病毒性肝炎相关肝癌外 科综合...
艾滋病行业研究状况
研究机构和非政府组织的伙伴合作力度,开展综合艾滋病防治活动,全方位 协助中国...活动 内容涉及艾滋病治疗的临床研究和公共及社区防治教育项目等。例如,葛兰素史 ...
国家重大科技专项课题名单
国家重大科技专项课题名单_信息与通信_工程科技_专业...的综合性新药研发技术大平 台建设 综合性新药研究...中国医药工业研究总院 艾滋病肝炎:序号 1 2 3 4 ...
中英性病艾滋病防治合作项目
本资料由中英性病艾滋病防治合作项目办公室组织北京大学儿童青少年 卫生研究所的...综合报告 1、 文献检索的目的 通过对现有文献、报道、专家访谈等方式,对中国...
中国艾滋病现状
中国艾滋病现状_军事/政治_人文社科_专业资料。中国艾滋病现状艾滋病,获得性免疫缺陷综合症,是一种由人类免疫缺乏病毒的 反转录病毒感染后,因免疫系统受到破坏,逐渐...
国内外艾滋病研究进展
国内外艾滋病研究进展摘要:艾滋病,即获得性免疫缺陷综合征,英文名称 Acquired ...1995 年中国艾滋病感染人数从此前的几百例一下子蹿 升到 1567 例,其中绝大...
国内外艾滋病研究进展
国内外艾滋病研究进展 摘要: 艾滋病, 即获得性免疫缺陷综合征, 英文名称 ...1995 年中国艾滋 病感染人数从此前的几百例一下子蹿升到 1567 例,其中绝大...
基线调查实施方案:艾滋病综合防治示范区
艾滋病综合防治示范区基线调查 实施方案 中国疾病预防控制中心 性病艾滋病预防控制中心 艾滋病综合防治示范区项目组 2003 年 5 月 1 艾滋病综合防治示范区基线调查...
中英艾滋病项目简介
当前我国艾滋孤儿研究综述 13页 免费 中盖艾滋病项目...狼性管理-宗鹏 12页 免费 通过综合措施减少艾滋病 ...项目背景 中国目前正面临着艾滋病严峻挑战.根据卫生...
99aids_down_007
参加本工作的项目成员有程峰研究员 、毕力和张云 ...我们要特别感谢中国性病艾滋病防治协会会长戴志澄教 ...流行病学、卫生经济和社区健康促进的综合性评估调查,...
更多相关标签: